Less than a century after it was rediscovered, National Geographic's correspondent explored the ruins of Petra and found its ...
Galapagos has had to send its SIK inhibitor programme back to the drawing board after its lead compound GLPG3970 has failed two of three clinical trials, adding to a string of disappointments for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback